Arca
Skip to content
Tools
Tools

mer-/-mer

Mercury-containing drugs, once used as antiseptics or diuretics.

  • Drugs containing mer-/-mer: 37
  • Approved somewhere: 13
  • With a US drug page: 9

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
mer-/-mer
Class
Mercury-containing drugs, once used as antiseptics or diuretics
Most common targets
Potassium (3), DNA (2), Phosphate (2), TCDA (2), TCDB (2), CFTR (1), ANO1 (1), Bacterial penicillin-binding protein (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names containing mer-/-mer, matched by spelling; those with a US drug page link to it.
Acts on
Berdazimer sodiumApproved—Releases NO, antimicrobial
CrofelemerApprovedCFTR, ANO1Cystic fibrosis transmembrane conductance regulator inhibitor
Glatiramer acetateApproved—Unknown
MeropenemApprovedBacterial penicillin-binding proteinBacterial penicillin-binding protein inhibitor
Patiromer sorbitex calciumApprovedPotassiumPotassium chelating agent
Porfimer sodiumApprovedDNADNA inhibitor
SevelamerApproved—Unknown
Sevelamer hydrochlorideApprovedPhosphatePhosphate sequestering agent
SuccimerPhase 2LeadLead chelating agent
Cadexomer iodineApproved—Unknown
DextranomerApproved—Unknown
Mercaptopurine anhydrousApprovedPPAT, DNAAmidophosphoribosyltransferase inhibitor
MersalylApproved—Unknown
Patiromer calciumApprovedPotassiumPotassium chelating agent
AstodrimerPhase 3—Surfactant
PatiromerPhase 3PotassiumPotassium chelating agent
PoloxamerPhase 3——
Tolevamer potassium sodiumPhase 3TCDA, TCDBToxin A binding agent
VepoloxamerPhase 3——
VeverimerPhase 3Hydrochloric acidHydrochloric acid sequestering agent
Azoximer bromidePhase 2—Immunomodulator
Carbomer 910Phase 2——
CrilanomerPhase 2——
DaniluromerPhase 2——
MerestinibPhase 2METHepatocyte growth factor receptor inhibitor
MericitabinePhase 2NS5BRNA-directed RNA polymerase inhibitor
MerimepodibPhase 2IMPDH1Inosine-5'-monophosphate dehydrogenase 1 inhibitor
OnterodrimerPhase 2——
Pegfosimer manganesePhase 2——
Plovamer acetatePhase 2HLA-DRB1HLA class II histocompatibility antigen, DRB1-15 beta chain modulator
Astodrimer sodiumPhase 1——
Carbomer homopolymer type b (allyl pentaerythritol crosslinked)Phase 1——
Flurimedrimer (18F)Phase 1——
TedromerPhase 1——
Bixalomer—PhosphatePhosphate sequestering agent
Merethoxylline procaine—Sodium channel alpha subunitSodium channel alpha subunit blocker
Tolevamer sodium—TCDA, TCDBToxin A binding agent

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.